Strategic Capital Advisers, Inc. Johnson & Johnson Transaction History

Strategic Capital Advisers, Inc.

$121 Million
Q2 2022

A detailed history of Strategic Capital Advisers, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Strategic Capital Advisers, Inc. holds 16,396 shares of JNJ stock, worth $2.39 Million. This represents 2.4% of its overall portfolio holdings.

Number of Shares

16,396

Previous 15,353 6.79%

Holding current value

$2.39 Million

Previous $2.72 Million 6.98%

% of portfolio

2.4%

Previous 2.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$168.19 - $186.01 $175,422 - $194,008	1,043 Added 6.79%	16,396 $2.91 Million
Q1 2022 May 05, 2022	SELL	$158.14 - $179.59 $115,600 - $131,280	-731 Reduced 4.54%	15,353 $2.72 Million
Q4 2021 Jan 19, 2022	BUY	$155.93 - $173.01 $231,867 - $257,265	1,487 Added 10.19%	16,084 $2.75 Million
Q3 2021 Oct 29, 2021	SELL	$161.5 - $179.47 $8,559 - $9,511	-53 Reduced 0.36%	14,597 $2.36 Million
Q2 2021 Jul 30, 2021	SELL	$159.48 - $171.07 $58,210 - $62,440	-365 Reduced 2.43%	14,650 $2.41 Million
Q1 2021 Apr 28, 2021	SELL	$153.07 - $170.48 $258,382 - $287,770	-1,688 Reduced 10.11%	15,015 $2.47 Million
Q4 2020 Jan 27, 2021	BUY	$137.11 - $157.38 $24,131 - $27,698	176 Added 1.06%	16,703 $2.63 Million
Q3 2020 Nov 10, 2020	BUY	$140.38 - $153.83 $228,257 - $250,127	1,626 Added 10.91%	16,527 $2.46 Million
Q2 2020 Aug 06, 2020	SELL	$128.81 - $155.51 $44,825 - $54,117	-348 Reduced 2.28%	14,901 $2.1 Million
Q1 2020 May 12, 2020	BUY	$111.14 - $153.99 $4,556 - $6,313	41 Added 0.27%	15,249 $2 Million
Q4 2019 Jan 27, 2020	SELL	$127.5 - $146.44 $255 - $292	-2 Reduced 0.01%	15,208 $2.22 Million
Q3 2019 Nov 05, 2019	BUY	$126.95 - $142.14 $888 - $994	7 Added 0.05%	15,210 $1.97 Million
Q2 2019 Jul 30, 2019	SELL	$131.15 - $144.24 $110,690 - $121,738	-844 Reduced 5.26%	15,203 $2.12 Million
Q1 2019 May 08, 2019	BUY	$125.72 - $139.79 $41,739 - $46,410	332 Added 2.11%	16,047 $2.24 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $720,947 - $867,672	-5,869 Reduced 27.19%	15,715 $2.03 Million
Q3 2018 Oct 29, 2018	BUY	$121.58 - $142.88 $729 - $857	6 Added 0.03%	21,584 $2.98 Million
Q2 2018 Aug 10, 2018	BUY	$119.4 - $131.76 $1.02 Million - $1.13 Million	8,558 Added 65.73%	21,578 $2.79 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $1.71 Million - $1.87 Million	13,020	13,020 $1.82 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Capital Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Strategic Capital Advisers, Inc. with notifications on news.

Account

Strategic Capital Advisers, Inc. Johnson & Johnson Transaction History